Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering novel therapeutics that have the potential to restore synapses to improve the lives of patients worldwide, today announced that ...
Xenon nears a Q3 2026 NDA with strong Phase 3 epilepsy data and a cash runway to 2029. Click here to read an analysis of XENE ...
So far, there are no confirmed cases of cyclosporiasis in Belmont County. But the health department is fielding questions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results